Lord, Abbett & Co’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-106,018
Closed -$15.2M 561
2023
Q3
$15.2M Sell
106,018
-54,128
-34% -$8.82M 0.06% 352
2023
Q2
$29.5M Buy
+160,146
New +$26.2M 0.1% 269
2020
Q2
Sell
-176,380
Closed -$14.1M 678
2020
Q1
$14.1M Buy
176,380
+5,283
+3% +$472K 0.06% 374
2019
Q4
$15.1M Buy
171,097
+3,789
+2% +$327K 0.05% 444
2019
Q3
$13.7M Buy
167,308
+7,423
+5% +$603K 0.05% 478
2019
Q2
$15.1M Sell
159,885
-690
-0.4% -$58.9K 0.05% 471
2019
Q1
$13.6M Buy
+160,575
New +$12.1M 0.05% 501

Other funds holding NOVT

Lord, Abbett & Co's NOVT Position: Q4 2023 in Review

Lord, Abbett & Co sold out of Novanta (NOVT) in Q4 2023, closing a stake of 106,018 shares — an estimated $15.2M sold.

Lord, Abbett & Co first reported a position in NOVT in Q1 2019 and held it in 7 quarters. The position peaked at $29.5M in Q2 2023. 257 funds tracked by Wall St. Rank hold NOVT as of Q4 2023.

  • Lord, Abbett & Co reported no remaining Novanta position as of Q4 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 106,018 Novanta shares in Q4 2023, an estimated $15.2M.
  • Lord, Abbett & Co first reported a position in Novanta in Q1 2019 and held it in 7 quarters.
  • Lord, Abbett & Co's Novanta position peaked at $29.5M in Q2 2023.
  • 257 funds tracked by Wall St. Rank held Novanta as of Q4 2023.

Based on Lord, Abbett & Co's 13F filing for Q4 2023, filed 12 Feb 2024.